Sullivan LE - Search Results

1

A trial of integrated buprenorphine/naloxone and HIV clinical care.

Sullivan LE, Barry D, Moore BA, Chawarski MC, Tetrault JM, Pantalon MV, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S184-90. doi: 10.1086/508182. Clin Infect Dis. 2006. PMID: 17109305 Clinical Trial.

2

Hepatitis C and HIV infections: implications for clinical care in injection drug users.

Sullivan LE, Fiellin DA. Sullivan LE, et al. Am J Addict. 2004 Jan-Feb;13(1):1-20. doi: 10.1080/10550490490265271. Am J Addict. 2004. PMID: 14766434 Review.

3

The practice of office-based buprenorphine treatment of opioid dependence: is it associated with new patients entering into treatment?

Sullivan LE, Chawarski M, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. Drug Alcohol Depend. 2005 Jul;79(1):113-6. doi: 10.1016/j.drugalcdep.2004.12.008. Drug Alcohol Depend. 2005. PMID: 15943950 Clinical Trial.

4

Buprenorphine: its role in preventing HIV transmission and improving the care of HIV-infected patients with opioid dependence.

Sullivan LE, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2005 Sep 15;41(6):891-6. doi: 10.1086/432888. Epub 2005 Aug 10. Clin Infect Dis. 2005. PMID: 16107991 Review.

5

Counseling plus buprenorphine-naloxone maintenance therapy for opioid dependence.

Fiellin DA, Pantalon MV, Chawarski MC, Moore BA, Sullivan LE, O'Connor PG, Schottenfeld RS. Fiellin DA, et al. Among authors: sullivan le. N Engl J Med. 2006 Jul 27;355(4):365-74. doi: 10.1056/NEJMoa055255. N Engl J Med. 2006. PMID: 16870915 Free article. Clinical Trial.

6

Initial strategies for integrating buprenorphine into HIV care settings in the United States.

Sullivan LE, Bruce RD, Haltiwanger D, Lucas GM, Eldred L, Finkelstein R, Fiellin DA. Sullivan LE, et al. Clin Infect Dis. 2006 Dec 15;43 Suppl 4:S191-6. doi: 10.1086/508183. Clin Infect Dis. 2006. PMID: 17109306 Review.

7

Training HIV physicians to prescribe buprenorphine for opioid dependence.

Sullivan LE, Tetrault J, Bangalore D, Fiellin DA. Sullivan LE, et al. Subst Abus. 2006 Sep;27(3):13-8. doi: 10.1300/J465v27n03_03. Subst Abus. 2006. PMID: 17135176

8

Patient satisfaction with primary care office-based buprenorphine/naloxone treatment.

Barry DT, Moore BA, Pantalon MV, Chawarski MC, Sullivan LE, O'Connor PG, Schottenfeld RS, Fiellin DA. Barry DT, et al. Among authors: sullivan le. J Gen Intern Med. 2007 Feb;22(2):242-5. doi: 10.1007/s11606-006-0050-y. J Gen Intern Med. 2007. PMID: 17356993 Free PMC article. Clinical Trial.

9

Primary care office-based buprenorphine treatment: comparison of heroin and prescription opioid dependent patients.

Moore BA, Fiellin DA, Barry DT, Sullivan LE, Chawarski MC, O'Connor PG, Schottenfeld RS. Moore BA, et al. Among authors: sullivan le. J Gen Intern Med. 2007 Apr;22(4):527-30. doi: 10.1007/s11606-007-0129-0. J Gen Intern Med. 2007. PMID: 17372805 Free PMC article.

10

Buprenorphine/naloxone treatment in primary care is associated with decreased human immunodeficiency virus risk behaviors.

Sullivan LE, Moore BA, Chawarski MC, Pantalon MV, Barry D, O'Connor PG, Schottenfeld RS, Fiellin DA. Sullivan LE, et al. J Subst Abuse Treat. 2008 Jul;35(1):87-92. doi: 10.1016/j.jsat.2007.08.004. Epub 2007 Oct 15. J Subst Abuse Treat. 2008. PMID: 17933486 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

74 results

Search Page

Filters